HLB today announced that its US subsidiary, Elevar Therapeutics, has signed a regulatory consulting agreement with a European pharmaceutical company.
 

Please refer to the following website for further details : HLB's US Subsidiary Signs Licensing Consultancy Agreement with European Pharma for Liver Cancer Drug < Health < IT Wellness < 기사본문 - IT Times